- Home
- BNTC vs ABSI Comparison
BNTC vs ABSI Comparison
Compare BNTC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- ABSI
- Stock Information
- Founded
- BNTC 1995
- ABSI 2011
- Country
- BNTC United States
- ABSI United States
- Employees
- BNTC N/A
- ABSI N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- BNTC Health Care
- ABSI Health Care
- Exchange
- BNTC Nasdaq
- ABSI Nasdaq
- Market Cap
- BNTC 339.8M
- ABSI 318.2M
- IPO Year
- BNTC N/A
- ABSI 2021
- Fundamental
- Price
- BNTC $15.34
- ABSI $3.21
- Analyst Decision
- BNTC Strong Buy
- ABSI Strong Buy
- Analyst Count
- BNTC 7
- ABSI 7
- Target Price
- BNTC $24.43
- ABSI $8.57
- AVG Volume (30 Days)
- BNTC 34.2K
- ABSI 4.7M
- Earning Date
- BNTC 05-12-2025
- ABSI 03-18-2025
- Dividend Yield
- BNTC N/A
- ABSI N/A
- EPS Growth
- BNTC N/A
- ABSI N/A
- EPS
- BNTC N/A
- ABSI N/A
- Revenue
- BNTC N/A
- ABSI $4,207,000.00
- Revenue This Year
- BNTC N/A
- ABSI $7.92
- Revenue Next Year
- BNTC N/A
- ABSI $162.34
- P/E Ratio
- BNTC N/A
- ABSI N/A
- Revenue Growth
- BNTC N/A
- ABSI N/A
- 52 Week Low
- BNTC $4.75
- ABSI $2.45
- 52 Week High
- BNTC $15.97
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- BNTC 72.14
- ABSI 41.23
- Support Level
- BNTC $11.99
- ABSI $2.90
- Resistance Level
- BNTC $13.00
- ABSI $3.26
- Average True Range (ATR)
- BNTC 1.05
- ABSI 0.28
- MACD
- BNTC 0.35
- ABSI -0.09
- Stochastic Oscillator
- BNTC 89.40
- ABSI 22.26
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.